Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Oral granules for treating mumps and preparation method thereof

A kind of mumps, granule technology, applied in the direction of anti-inflammatory agent, non-central analgesic, medical preparation containing active ingredients, etc., to achieve the effect of inhibiting virus infection, good clinical application prospect and easy to use

Inactive Publication Date: 2016-07-20
张伟强
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no specific drug for mumps. Antibiotics are ineffective in the treatment of this disease. Clinical treatment is mainly aimed at symptomatic medication. Isolate the patient and make him rest in bed until the swelling of the parotid gland completely subsides. For example, pay attention to oral hygiene and improve eating habits in time to ensure fluid intake Use antipyretic and analgesic drugs to lower body temperature; patients with meningoencephalitis should be given sedative and intracranial pressure-lowering drugs, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Embodiment 1: an oral granule for treating mumps, said oral granule comprises the following components: 5 parts of codeine, 3 parts of aristolochic acid, 8 parts of acaciacin, 5 parts of syringic acid, peony 4 parts of phenol, 12 parts of mint dew, 10 parts of riboflavin, 15 parts of pentosan, 0.3 parts of nabumetone, 0.5 parts of nitrofurantoin, 6 parts of allantoin, 26 parts of water-soluble arabinoxylan, mixed 5 parts of amino acid, 180 parts of cyclodextrin, and 360 parts of ethanol; the granules also include auxiliary materials: 8 parts of sweetener, 6.5 parts of disintegrant, and 3 parts of lubricant.

[0018] Wherein, the water-soluble arabinoxylan is produced by hydrolyzing rice bran, and arabinoxylan is a kind of edible fiber polysaccharide, which is produced by hydrolyzing rice bran with shiitake mushroom enzyme extract, which can effectively increase the activity of the immune system in clinical practice , especially for viral infectious diseases. The mass c...

Embodiment 2

[0023] Embodiment 2: an oral granule for treating mumps, said oral granule comprises the following components: 6.5 parts of codeine, 4.5 parts of aristolochic acid, 10 parts of locustine, 8.5 parts of syringic acid, peony 6 parts of phenol, 13.5 parts of mint dew, 14 parts of riboflavin, 17.5 parts of pentosan, 0.4 part of nabumetone, 0.7 part of nitrofurantoin, 7 parts of allantoin, 32 parts of water-soluble arabinoxylan, mixed 8.5 parts of amino acid, 215 parts of cyclodextrin, and 420 parts of ethanol; the granule also includes auxiliary materials: 11.5 parts of sweetener, 7.5 parts of disintegrant, and 4 parts of lubricant.

[0024] Wherein, the water-soluble arabinoxylan is produced by hydrolyzing rice bran, and arabinoxylan is a kind of edible fiber polysaccharide, which is produced by hydrolyzing rice bran with shiitake mushroom enzyme extract, which can effectively increase the activity of the immune system in clinical practice , especially for viral infectious disease...

Embodiment 3

[0030]An oral granule for treating mumps, the oral granule comprises the following components: 8 parts of codeine, 6 parts of aristolochic acid, 12 parts of acaciacin, 12 parts of syringic acid, 8 parts of paeonol, 15 parts of mint dew, 18 parts of riboflavin, 20 parts of pentosan, 0.5 parts of nabumetone, 0.9 parts of nitrofurantoin, 8 parts of allantoin, 38 parts of water-soluble arabinoxylan, 12 parts of mixed amino acids, 250 parts of cyclodextrin, 480 parts of ethanol; the granules also include auxiliary materials: 15 parts of sweetener, 8.5 parts of disintegrant, and 5 parts of lubricant.

[0031] Wherein, the water-soluble arabinoxylan is produced by hydrolyzing rice bran, and arabinoxylan is a kind of edible fiber polysaccharide, which is produced by hydrolyzing rice bran with shiitake mushroom enzyme extract, which can effectively increase the activity of the immune system in clinical practice , especially for viral infectious diseases. The mass concentration range o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses oral granules for treating the mumps and a preparation method thereof.The oral granules are prepared from codeine, aristolochic acid, robinin, syringic acid, paeonol, mint distillate, riboflavin, pentosans, nabumetone, nitrofurantoin, allantoin, water-soluble araboxylan, mixed amino acid, cyclodextrin and alcohol and other auxiliaries including sweetening agent, disintegrant and lubricant.Various western medicine components are reasonably combined, and the oral granules have functions of resisting infection, clearing away heat and toxic materials, and calming and stopping pain, can eliminate parotid gland swelling, resist virus infection and meanwhile enhance immunity of organism to promote the rapid rehabilitation of a patient, are easy to prepare and convenient to use and have quite good clinical application prospects.

Description

technical field [0001] The invention relates to the technical field of medicine in respiratory medicine, in particular to an oral granule for treating mumps and a preparation method thereof. Background technique [0002] In recent years, the incidence of mumps has been increasing, especially the characteristics of mumps infection through the respiratory tract is a major difficulty in prevention and treatment. The parotid gland is the largest salivary gland, located on both sides of the cheek near the earlobe The swelling of the parotid gland is centered on the earlobe, and can be on one side or both sides. The main symptoms of parotitis are infectious, immune, obstructive, and unexplained inflammation and swelling. The most common is parotitis caused by infection, which is more common in bacterial and viral. The most common viral parotitis is mumps, which is popular in all seasons, common in winter and spring, and children and adolescents are prone to this disease. Mumps is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/485A61K31/36A61K31/352A61K31/192A61K31/12A61K36/534A61K31/525A61K31/702A61K31/4178A61K31/4166A61K31/715A61K9/16A61P31/12A61P29/00
CPCA61K31/485A61K9/1652A61K31/12A61K31/192A61K31/352A61K31/36A61K31/4166A61K31/4178A61K31/525A61K31/702A61K31/715A61K36/534
Inventor 张伟强
Owner 张伟强
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com